Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UiPath Stock Tumbles 15% on Dramatic Growth Slowdown, Guidance Embeds 'Significant Conservatism' Says Analyst

Published 03/31/2022, 06:17 AM
Updated 03/31/2022, 06:49 AM
© Reuters.  UiPath (PATH) Stock Tumbles 15% on Dramatic Growth Slowdown, Guidance Embeds 'Significant Conservatism' Says Analyst

Shares of Uipath (NYSE:PATH) are down nearly 15% in premarket trading Thursday after the company released a weaker-than-expected Q1 revenue forecast.

The software maker reported Q4 adjusted EPS of 5c, well above the analyst consensus of 2.6c per share. Total revenue in the quarter came in at $289.7 million.

For the first quarter, UiPath expects revenue in the range of $223 million to $225 million, missing the consensus estimates of $246.4 million. The company expects Q1 adjusted operating loss in the range of $25 million to $30 million.

"We have built a global business that serves customers in more than 115 countries, including countries across eastern Europe and Russia," said the company's CEO Daniel Dines.

Looking ahead, we feel confident in our market-leading position in automation and prospects for future growth at scale but believe it is prudent at this time to factor both our European exposure and go-to-market leadership transition into the financial outlook we are providing this afternoon.

Credit Suisse analyst Phil Winslow believes PATH's guidance reflects significant conservatism. The analyst slashed the price target to $57.50 from the prior $75.00.

To further frame the conservatism in terms of new vs. expansion business, FY2023 ARR guidance excluding headwinds would imply $0 ARR contribution from new customers and DBNRR declining from 145% to ~134% "despite maintaining a best-in-class range vs. 153% exiting FY2020. We reiterate our thesis that the market opportunity in terms of global automatable wages is both sizable and largely untapped, we believe that UiPath, with the only purpose-built, end-to-end hyperautomation platform, is leading the paradigm shift toward the fully-automated enterprise," Winslow said in a client note.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cowen analyst Bryan Bergin sees many moving parts in the PATH story after EPS.

PATH posted a broadly solid 4Q beating Street, but FY23 outlook disappoints. "While we understand this is not a story that needed added complexity, the sharp initial stock reaction (-14% AH) is overdone, in our view, when taking into account a host of uncontrollable impacts (Russia/FX) and an otherwise broadly positive pipeline and competitive positioning views," Bergin said in a memo to clients.

By Senad Karaahmetovic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.